Skip to main content

Articles

Page 6 of 97

  1. Epidemiologic studies have, variably, shown the concomitant use of statin drugs to be beneficial to cancer outcomes. Statin drugs have been FDA approved for three decades for the treatment of high cholesterol ...

    Authors: Colin H. Beckwitt, Adam Brufsky, Zoltán N. Oltvai and Alan Wells

    Citation: Breast Cancer Research 2018 20:144

    Content type: Review

    Published on:

  2. Lymph node (LN) metastasis is an important prognostic parameter in breast carcinoma, a crucial site for tumour–immune cell interaction and a gateway for further dissemination of tumour cells to other metastati...

    Authors: Gaurav Chatterjee, Trupti Pai, Thomas Hardiman, Kelly Avery-Kiejda, Rodney J. Scott, Jo Spencer, Sarah E. Pinder and Anita Grigoriadis

    Citation: Breast Cancer Research 2018 20:143

    Content type: Review

    Published on:

  3. Junctional adhesion molecule-A (JAM-A) is an adhesion molecule whose overexpression on breast tumor tissue has been associated with aggressive cancer phenotypes, including human epidermal growth factor recepto...

    Authors: Astrid O. Leech, Sri HariKrishna Vellanki, Emily J. Rutherford, Aoife Keogh, Hanne Jahns, Lance Hudson, Norma O’Donovan, Siham Sabri, Bassam Abdulkarim, Katherine M. Sheehan, Elaine W. Kay, Leonie S. Young, Arnold D. K. Hill, Yvonne E. Smith and Ann M. Hopkins

    Citation: Breast Cancer Research 2018 20:140

    Content type: Research article

    Published on:

  4. Early analyses of human breast cancer identified high expression of the insulin-like growth factor type 1 receptor (IGF-1R) correlated with hormone receptor positive breast cancer and associated with a favorab...

    Authors: Alison E. Obr, Sushil Kumar, Yun-Juan Chang, Joseph J. Bulatowicz, Betsy J. Barnes, Raymond B. Birge, Deborah A. Lazzarino, Emily Gallagher, Derek LeRoith and Teresa L. Wood

    Citation: Breast Cancer Research 2018 20:138

    Content type: Research article

    Published on:

  5. Cancer progression is influenced by genetic aberrations in the cancer cell population as well as by other factors including the microenvironment present within a tumour. Direct interactions between various cel...

    Authors: Sara Rhost, Éamon Hughes, Hannah Harrison, Svanheidur Rafnsdottir, Hanna Jacobsson, Pernilla Gregersson, Ylva Magnusson, Paul Fitzpatrick, Daniel Andersson, Karoline Berger, Anders Ståhlberg and Göran Landberg

    Citation: Breast Cancer Research 2018 20:137

    Content type: Research article

    Published on:

  6. Following publication of the original article [1], the authors reported a typesetting error in the spelling of the second author’s name.

    Authors: John A. Reid, Peter A. Mollica, Robert D. Bruno and Patrick C. Sachs

    Citation: Breast Cancer Research 2018 20:136

    Content type: Correction

    Published on:

    The original article was published in Breast Cancer Research 2018 20:122

  7. Inflammation is an important candidate mechanism underlying cancer and cancer treatment-related cognitive impairment. We investigated levels of blood cell–based inflammatory markers in breast cancer survivors ...

    Authors: Kimberly D. van der Willik, Vincent Koppelmans, Michael Hauptmann, Annette Compter, M. Arfan Ikram and Sanne B. Schagen

    Citation: Breast Cancer Research 2018 20:135

    Content type: Research article

    Published on:

  8. Osteoporosis, an indicator of significant bone loss, has been consistently reported among older breast cancer survivors. Data are limited on the incidence of osteopenia, an earlier indicator of bone loss, and ...

    Authors: Cody Ramin, Betty J. May, Richard B. S. Roden, Mikiaila M. Orellana, Brenna C. Hogan, Michelle S. McCullough, Dana Petry, Deborah K. Armstrong and Kala Visvanathan

    Citation: Breast Cancer Research 2018 20:134

    Content type: Research article

    Published on:

  9. We have previously shown that galactosylceramide (GalCer) affects the tumourigenic and metastatic properties of breast cancer cells by acting as an anti-apoptotic molecule. Since GalCer is a precursor molecule...

    Authors: Jaroslaw Suchanski, Jedrzej Grzegrzolka, Tomasz Owczarek, Pawel Pasikowski, Aleksandra Piotrowska, Bartlomiej Kocbach, Aleksandra Nowak, Piotr Dziegiel, Andrzej Wojnar and Maciej Ugorski

    Citation: Breast Cancer Research 2018 20:133

    Content type: Research article

    Published on:

  10. The association between body mass index (BMI) and risk of breast cancer depends on time of life, but it is unknown whether this association depends on a woman’s familial risk.

    Authors: John L. Hopper, Gillian S. Dite, Robert J. MacInnis, Yuyan Liao, Nur Zeinomar, Julia A. Knight, Melissa C. Southey, Roger L. Milne, Wendy K. Chung, Graham G. Giles, Jeanine M. Genkinger, Sue-Anne McLachlan, Michael L. Friedlander, Antonis C. Antoniou, Prue C. Weideman, Gord Glendon…

    Citation: Breast Cancer Research 2018 20:132

    Content type: Research article

    Published on:

  11. Amphiregulin (AREG), a ligand of the epidermal growth factor receptor, is not only essential for proper mammary ductal development, but also associated with breast cancer proliferation and growth. In the absen...

    Authors: Serena P. H. Mao, Minji Park, Ramon M. Cabrera, John R. Christin, George S. Karagiannis, Maja H. Oktay, Dietmar M. W. Zaiss, Scott I. Abrams, Wenjun Guo, John S. Condeelis, Paraic A. Kenny and Jeffrey E. Segall

    Citation: Breast Cancer Research 2018 20:131

    Content type: Research article

    Published on:

  12. De novo or acquired resistance in breast cancer leads to treatment failures and disease progression. In human epidermal growth factor receptor 2 (HER2)-positive (HER2+) breast cancer, Src, a non-receptor tyros...

    Authors: Brooke N. McKnight and Nerissa T. Viola-Villegas

    Citation: Breast Cancer Research 2018 20:130

    Content type: Research article

    Published on:

  13. Stem cells are precursors for all mammary epithelia, including ductal and alveolar epithelia, and myoepithelial cells. In vivo mammary epithelia reside in a tissue context and interact with their milieu via re...

    Authors: Safiah Olabi, Ahmet Ucar, Keith Brennan and Charles H. Streuli

    Citation: Breast Cancer Research 2018 20:128

    Content type: Research article

    Published on:

  14. Bone is one of the most frequent metastatic sites of advanced breast cancer. Current therapeutic agents aim to inhibit osteoclast-mediated bone resorption but only have palliative effects. During normal bone r...

    Authors: Xuxiang Liu, Minghui Cao, Melanie Palomares, Xiwei Wu, Arthur Li, Wei Yan, Miranda Y. Fong, Wing-Chung Chan and Shizhen Emily Wang

    Citation: Breast Cancer Research 2018 20:127

    Content type: Research article

    Published on:

  15. Although metastasis is ultimately responsible for about 90% of breast cancer mortality, the vast majority of breast-cancer-related deaths are due to progressive recurrences from non-metastatic disease. Current...

    Authors: Sruthi Ravindranathan, Khue G. Nguyen, Samantha L. Kurtz, Haven N. Frazier, Sean G. Smith, Bhanu prasanth Koppolu, Narasimhan Rajaram and David A. Zaharoff

    Citation: Breast Cancer Research 2018 20:126

    Content type: Research article

    Published on:

  16. Circadian rhythms maintain tissue homeostasis during the 24-h day-night cycle. Cell-autonomous circadian clocks play fundamental roles in cell division, DNA damage responses and metabolism. Circadian disruptio...

    Authors: Eleanor Broadberry, James McConnell, Jack Williams, Nan Yang, Egor Zindy, Angela Leek, Rachel Waddington, Leena Joseph, Miles Howe, Qing-Jun Meng and Charles H Streuli

    Citation: Breast Cancer Research 2018 20:125

    Content type: Research article

    Published on:

  17. Exercise is an effective strategy to improve quality of life and physical fitness in breast cancer survivors; however, few studies have focused on the early survivorship period, minorities, physically inactive...

    Authors: Christina M Dieli-Conwright, Kerry S Courneya, Wendy Demark-Wahnefried, Nathalie Sami, Kyuwan Lee, Frank C Sweeney, Christina Stewart, Thomas A Buchanan, Darcy Spicer, Debu Tripathy, Leslie Bernstein and Joanne E Mortimer

    Citation: Breast Cancer Research 2018 20:124

    Content type: Research article

    Published on:

  18. Endocrine therapy is recommended for patients with hormone receptor-positive (HR+) advanced and metastatic breast cancer without visceral crisis (symptomatic visceral disease). However, many patients experience d...

    Authors: Gabriel N. Hortobagyi

    Citation: Breast Cancer Research 2018 20:123

    Content type: Review

    Published on:

  19. The presence of disseminated tumor cells (DTCs) in bone marrow (BM) is an independent prognostic factor in early breast cancer but does not uniformly predict outcome. Tumor cells can persist in a quiescent sta...

    Authors: Elin Borgen, Maria C. Rypdal, Maria Soledad Sosa, Anne Renolen, Ellen Schlichting, Per E. Lønning, Marit Synnestvedt, Julio A. Aguirre-Ghiso and Bjørn Naume

    Citation: Breast Cancer Research 2018 20:120

    Content type: Short report

    Published on:

  20. Standard three-dimensional (3D) in vitro culture techniques, such as those used for mammary epithelial cells, rely on random distribution of cells within hydrogels. Although these systems offer advantages over tr...

    Authors: John A. Reid, Peter A. Mollica, Robert D. Bruno and Patrick C. Sachs

    Citation: Breast Cancer Research 2018 20:122

    Content type: Research article

    Published on:

    The Correction to this article has been published in Breast Cancer Research 2018 20:136

  21. Exposure to road traffic noise was associated with increased risk of estrogen receptor (ER)-negative (ER-) breast cancer in a previous cohort study, but not with overall or ER-positive (ER+) breast cancer, or ...

    Authors: Zorana Jovanovic Andersen, Jeanette Therming Jørgensen, Lea Elsborg, Søren Nymand Lophaven, Claus Backalarz, Jens Elgaard Laursen, Torben Holm Pedersen, Mette Kildevæld Simonsen, Elvira Vaclavik Bräuner and Elsebeth Lynge

    Citation: Breast Cancer Research 2018 20:119

    Content type: Research article

    Published on:

  22. The most life-threatening step during malignant tumor progression is reached when cancer cells leave the primary tumor mass and seed metastasis in distant organs. To infiltrate the surrounding tissue and disse...

    Authors: Nathalie Meyer-Schaller, Chantal Heck, Stefanie Tiede, Mahmut Yilmaz and Gerhard Christofori

    Citation: Breast Cancer Research 2018 20:118

    Content type: Research article

    Published on:

  23. Metastasis is responsible for a significant number of breast cancer-related deaths. Hypoxia, a primary driving force of cancer metastasis, induces the expression of BHLHE40, a transcription regulator. This stu...

    Authors: Aarti Sethuraman, Martin Brown, Raya Krutilina, Zhao-Hui Wu, Tiffany N. Seagroves, Lawrence M. Pfeffer and Meiyun Fan

    Citation: Breast Cancer Research 2018 20:117

    Content type: Research article

    Published on:

  24. Increased collagen expression and deposition are associated with cancer progression and poor prognosis in breast cancer patients. However, function and regulation of membrane-associated collagen in breast canc...

    Authors: Hui Zhang, Tricia Fredericks, Gaofeng Xiong, Yifei Qi, Piotr G. Rychahou, Jia-Da Li, Taina Pihlajaniemi, Wei Xu and Ren Xu

    Citation: Breast Cancer Research 2018 20:116

    Content type: Research article

    Published on:

  25. Previous studies on the role of TP53 mutation in breast cancer treatment response and survival are contradictory and inconclusive, limited by the use of different endpoints to determine clinical significance and ...

    Authors: Nathan A. Ungerleider, Sonia G. Rao, Ashkan Shahbandi, Douglas Yee, Tianhua Niu, Wesley D. Frey and James G. Jackson

    Citation: Breast Cancer Research 2018 20:115

    Content type: Research article

    Published on:

  26. Limited evidence, mostly from studies in Western populations, suggests that the prognostic effects of lifestyle-related risk factors may be molecular subtype-dependent. Here, we examined whether pre-diagnostic...

    Authors: Mustapha Abubakar, Hyuna Sung, Devi BCR, Jennifer Guida, Tieng Swee Tang, Ruth M. Pfeiffer and Xiaohong R. Yang

    Citation: Breast Cancer Research 2018 20:114

    Content type: Research article

    Published on:

  27. Drug resistance of paclitaxel (TAX), the first-line chemotherapy drug for breast cancer, was reported to develop in 90% of patients with breast cancer, especially metastatic breast cancer. Investigating the me...

    Authors: Liu Yang, Yanhua Tian, Wei Sun Leong, Heng Song, Wei Yang, Meiqi Wang, Xinle Wang, Jing Kong, Baoen Shan and Zhengchuan Song

    Citation: Breast Cancer Research 2018 20:113

    Content type: Research article

    Published on:

  28. Tamoxifen is typically used to treat patients with estrogen receptor alpha (ERα)-positive breast cancer. However, 30% of these patients gain acquired resistance to tamoxifen during or after tamoxifen treatment...

    Authors: Pin Gao, Xiang Wang, Ying Jin, Wenquan Hu, Yajun Duan, Aiping Shi, Ye Du, Dong Song, Ming Yang, Sijie Li, Bing Han, Gang Zhao, Hongquan Zhang, Zhimin Fan and Qing Robert Miao

    Citation: Breast Cancer Research 2018 20:112

    Content type: Research article

    Published on:

  29. Antimicrobial T cells play key roles in the disease progression of cancers arising in mucosal epithelial tissues, such as the colon. However, little is known about microbe-reactive T cells within human breast ...

    Authors: Nicholas A. Zumwalde, Jill D. Haag, Michael N. Gould and Jenny E. Gumperz

    Citation: Breast Cancer Research 2018 20:111

    Content type: Research article

    Published on:

  30. This phase Ib study (NCT00960960) evaluated pictilisib (GDC-0941; pan-phosphatidylinositol 3-kinase inhibitor) plus paclitaxel, with and without bevacizumab or trastuzumab, or in combination with letrozole, in...

    Authors: Patrick Schöffski, Sara Cresta, Ingrid A. Mayer, Hans Wildiers, Silvia Damian, Steven Gendreau, Isabelle Rooney, Kari M. Morrissey, Jill M. Spoerke, Vivian W. Ng, Stina M. Singel and Eric Winer

    Citation: Breast Cancer Research 2018 20:109

    Content type: Research article

    Published on:

  31. Breast cancer has been considered not highly immunogenic, and few patients benefit from current immunotherapies. However, new strategies are aimed at changing this paradigm. In the present study, we examined t...

    Authors: Roberto R. Rosato, Daniel Dávila-González, Dong Soon Choi, Wei Qian, Wen Chen, Anthony J. Kozielski, Helen Wong, Bhuvanesh Dave and Jenny C. Chang

    Citation: Breast Cancer Research 2018 20:108

    Content type: Research article

    Published on:

  32. After the publication of this article [1], we noticed that in Fig. 2, the survival curve images (C and D, lower panel) were incorrect. The corrected Fig. 2 is presented below. The correction does not affect in...

    Authors: Aya Asano, Shigeto Ueda, Ichiei Kuji, Tomohiko Yamane, Hideki Takeuchi, Eiko Hirokawa, Ikuko Sugitani, Hiroko Shimada, Takahiro Hasebe, Akihiko Osaki and Toshiaki Saeki

    Citation: Breast Cancer Research 2018 20:107

    Content type: Correction

    Published on:

    The original article was published in Breast Cancer Research 2018 20:78

  33. Invasive lobular breast carcinoma (ILC) is a histological subtype of breast cancer that is characterized by loss of E-cadherin and high expression of estrogen receptor alpha (ERα). In many cases, ILC is effect...

    Authors: Tian Du, Matthew J. Sikora, Kevin M. Levine, Nilgun Tasdemir, Rebecca B. Riggins, Stacy G. Wendell, Bennett Van Houten and Steffi Oesterreich

    Citation: Breast Cancer Research 2018 20:106

    Content type: Research article

    Published on:

  34. Development of distant metastases involves a complex multistep biological process termed the invasion-metastasis cascade, which includes dissemination of cancer cells from the primary tumor to secondary organs. N...

    Authors: Alexey A. Leontovich, Mohammad Jalalirad, Jeffrey L. Salisbury, Lisa Mills, Candace Haddox, Mark Schroeder, Ann Tuma, Maria E. Guicciardi, Luca Zammataro, Mario W. Gambino, Angela Amato, Aldo Di Leonardo, James McCubrey, Carol A. Lange, Minetta Liu, Tufia Haddad…

    Citation: Breast Cancer Research 2018 20:105

    Content type: Research article

    Published on:

  35. Obesity is a strong predictor of poor prognosis in breast cancer, especially in postmenopausal women. In particular, tumors in obese patients tend to seed more distant metastases, although the biology behind t...

    Authors: Mélanie Bousquenaud, Flavia Fico, Giovanni Solinas, Curzio Rüegg and Albert Santamaria-Martínez

    Citation: Breast Cancer Research 2018 20:104

    Content type: Research article

    Published on:

  36. Several prognostic signatures for early oestrogen receptor-positive (ER+) breast cancer have been established with a 10-year follow-up. We tested the hypothesis that signatures optimised for 0–5-year and 5–10-...

    Authors: Richard Buus, Belinda Yeo, Adam R. Brentnall, Marie Klintman, Maggie Chon U. Cheang, Komel Khabra, Ivana Sestak, Qiong Gao, Jack Cuzick and Mitch Dowsett

    Citation: Breast Cancer Research 2018 20:103

    Content type: Research article

    Published on:

  37. The European Network for Breast Development and Cancer (ENBDC), a worldwide network (http://​www.​enbdc.​org/​), celebrated its tenth anniversary with a fantasti...

    Authors: Zuzana Koledova, Beatrice A. Howard, Johanna Englund, Karsten Bach, Mohammed Bentires-Alj and Eva Gonzalez-Suarez

    Citation: Breast Cancer Research 2018 20:102

    Content type: Meeting report

    Published on:

  38. We sought to investigate associations between dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) features and tumor-infiltrating lymphocytes (TILs) in breast cancer, as well as to study if MRI fe...

    Authors: Jia Wu, Xuejie Li, Xiaodong Teng, Daniel L. Rubin, Sandy Napel, Bruce L. Daniel and Ruijiang Li

    Citation: Breast Cancer Research 2018 20:101

    Content type: Research article

    Published on:

  39. Differentiation of stem cells into highly specialised cells requires gene expression changes brought about by remodelling of the chromatin architecture. During this lineage-commitment process, the majority of ...

    Authors: Holly Holliday, Laura A. Baker, Simon R. Junankar, Susan J. Clark and Alexander Swarbrick

    Citation: Breast Cancer Research 2018 20:100

    Content type: Review

    Published on:

  40. While many studies have shown that maternal factors in pregnancy affect the cancer risk for offspring, few studies have investigated the impact of paternal exposures on their progeny’s risk of this disease. Po...

    Authors: Raquel Santana da Cruz, Elissa J. Carney, Johan Clarke, Hong Cao, M. Idalia Cruz, Carlos Benitez, Lu Jin, Yi Fu, Zuolin Cheng, Yue Wang and Sonia de Assis

    Citation: Breast Cancer Research 2018 20:99

    Content type: Research article

    Published on:

  41. After the publication of this work [1], an error was noticed in Fig. 2b and Fig. 4b as well as Fig. 4b. and Fig. 5d. Images of the ERK1/2 blots were accidentally duplicated. In Fig. 5a. and Fig. 5c., the last ...

    Authors: Iain R. Hutcheson, Janice M. Knowlden, Steve E. Hiscox, Denise Barrow, Julia M. W. Gee, John F. Robertson, Ian O. Ellis and Robert I. Nicholson

    Citation: Breast Cancer Research 2018 20:98

    Content type: Correction

    Published on:

    The original article was published in Breast Cancer Research 2007 9:R50

  42. Although ductal carcinoma in situ (DCIS) is a non-invasive breast cancer, many DCIS lesions may progress to invasive cancer and the genes and pathways responsible for its progression are largely unknown. FGFR1...

    Authors: Mao Yang, Xiaobin Yu, Xuesen Li, Bo Luo, Wenli Yang, Yan Lin, Dabing Li, Zhonglin Gan, Jianming Xu and Tao He

    Citation: Breast Cancer Research 2018 20:97

    Content type: Research article

    Published on:

  43. We evaluated the association between volumetric breast density (BD) and risk of advanced cancers after a negative screening episode.

    Authors: Donella Puliti, Marco Zappa, Paolo Giorgi Rossi, Elena Pierpaoli, Gianfranco Manneschi, Daniela Ambrogetti, Leonardo Ventura and Paola Mantellini

    Citation: Breast Cancer Research 2018 20:95

    Content type: Research article

    Published on:

  44. Thyroxine (T4) has been positively associated with tumor cell proliferation, while the effect of triiodothyronine (T3) on cell proliferation has not been well-established because it differs according to the ty...

    Authors: Carolina Ortega-Olvera, Alfredo Ulloa-Aguirre, Angélica Ángeles-Llerenas, Fernando Enrique Mainero-Ratchelous, Claudia Elena González-Acevedo, Ma. de Lourdes Hernández-Blanco, Elad Ziv, Larissa Avilés-Santa, Edelmiro Pérez-Rodríguez and Gabriela Torres-Mejía

    Citation: Breast Cancer Research 2018 20:94

    Content type: Research article

    Published on:

  45. Epidemiological studies have consistently shown that increased mammographic density (MD) is a strong risk factor for breast cancer. We previously observed an elevated number of vimentin+/CD45+ leukocytes in high ...

    Authors: Cecilia W. Huo, Prue Hill, Grace Chew, Paul J. Neeson, Heloise Halse, Elizabeth D. Williams, Michael A. Henderson, Erik W. Thompson and Kara L. Britt

    Citation: Breast Cancer Research 2018 20:92

    Content type: Research article

    Published on:

  46. Fibroadenomas are common benign breast lesions, and studies of European American women indicate a persistent, increased risk of breast cancer after diagnosing a fibroadenoma on biopsy. This association has not...

    Authors: Asra N. Shaik, Julie J. Ruterbusch, Eman Abdulfatah, Resha Shrestha, M. H. D. Fayez Daaboul, Visakha Pardeshi, Daniel W. Visscher, Sudeshna Bandyopadhyay, Rouba Ali-Fehmi and Michele L. Cote

    Citation: Breast Cancer Research 2018 20:91

    Content type: Research article

    Published on:

  47. Upregulation of human epidermal growth factor receptor 3 (HER3) is a major mechanism of acquired resistance to therapies targeting its heterodimerization partners epidermal growth factor receptor (EGFR) and hu...

    Authors: Takuya Osada, Zachary C. Hartman, Junping Wei, Gangjun Lei, Amy C. Hobeika, William R. Gwin, Marcio A. Diniz, Neil Spector, Timothy M. Clay, Wei Chen, Michael A. Morse and H. Kim Lyerly

    Citation: Breast Cancer Research 2018 20:90

    Content type: Research article

    Published on:

Annual Journal Metrics